Dr. Wang Tao has resigned from his position as Employee Representative Supervisor of the company for personal career development reasons, effective December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department, was democratically elected as the Employee Representative Supervisor for the second term of the Board of Supervisors on December 31, 2025. Dr. Shi's term commenced on December 31, 2025, and will expire upon the conclusion of the second term of the Board of Supervisors.